Market Capitalization (Millions $) |
776 |
Shares
Outstanding (Millions) |
45 |
Employees |
- |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
-238 |
Cash Flow (TTM) (Millions $) |
-53 |
Capital Exp. (TTM) (Millions $) |
1 |
Viridian Therapeutics Inc
Viridian Therapeutics Inc is a biotechnology company that focuses on developing treatments for metabolic diseases. The company is known for its expertise in gene therapy and its innovative approach to developing personalized medicines. Viridian Therapeutics aims to address various metabolic diseases, such as obesity and type 2 diabetes, by targeting specific genetic factors and developing targeted therapies. The company takes advantage of advances in genomic research to identify genetic mutations and develop treatments that directly address the underlying causes of metabolic diseases. With a strong emphasis on personalized medicine, Viridian Therapeutics aims to revolutionize the way metabolic diseases are treated by providing tailored therapies that are specifically designed for each patient.
Company Address: 221 Crescent Street, Suite 401 Waltham 2453 MA
Company Phone Number: 272-4600 Stock Exchange / Ticker: NASDAQ VRDN
|